Financial Highlights | Lee's Pharmaceutical

Financial Highlights

For the year ended 31 December
HK$'000
2022
2021
Change
Revenue
1,233,148
1,266,157
-2.6%
Gross Profit
770,755
806,284
-4.4%
Gross Profit Margin (%)
62.5%
63.7%
-1.2%
EBITDA
213,992
2,110,444
-89.9%
Profit from Operations
76,560
1,978,583
-96.1%
Profit attributable to shareholders of the Company
51,284
1,987,176
-97.4%
Equity attributable to the owners of the Company
1,924,107
2,464,578
-21.9%
Basic EPS
HK 8.71 cents
HK 337.58 cents
-97.4%
Diluted EPS
HK 8.71 cents
HK 337.35 cents
-97.4%
Total Dividend per Share (Interim + Final)
HK 2.00 cents
HK 6.10 cents
-67.2%